Formulation of human antibodies for treating TNF-alpha associated disorders | Patent Number 09220781
US 09220781 B2Filled DateJul 14, 2015
Priority DateAug 16, 2002
Publication DateOct 29, 2015
Expiration DateAug 16, 2022
Inventor/ApplicantsHans-Juergen Krause
Michael Dickes
Lisa Baust
Michael Dickes
Lisa Baust
ExaminesBUNNER, BRIDGET E
Art Unit1647
Technology Center1600
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramSee the invalidated claims, subscribe to our Concierge Program.
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.